Recruiting Nephron-sparing Treatment of Tislelizumab + Nab-Paclitaxel for Renal Pelvic Cancer NCT07233252 Conditions Kidney-sparing, Nab-paclitaxel, PD-1 Inhibitor, +2 more Locations The Second Hospital of Tianjin Medical University — Tianjin, Outside U.S., China View Trial Details
Recruiting Postoperative Adjuvant Immunotherapy Combined with Radiotherapy Versus Surgery Alone in Locally Advanced UTUC NCT06598761 Conditions Advanced Urothelial Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more Locations Departmeng of Urology, Peking University First Hospital — Beijing, China Department of Radiotherapy Oncology, Peking University First Hospital — Beijing, China View Trial Details
Recruiting Radiotherapy Combined with Systemic Therapy Versus Systemic Therapy for Oligometastatic UTUCs NCT06652022 Conditions Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +11 more Locations Departmeng of Urology, Peking University First Hospital — Beijing, China Department of Radiotherapy Oncology, Peking University First Hospital — Beijing, China View Trial Details
